August 3, 2022 – Dandelion Health announced the launch of an integrated data platform that allows healthcare and life sciences companies to securely and ethically access representative, high-quality clinical patient data—including images, waveforms and structured health records—to enable the broader industry to build novel AI products, from aiding and automating medical decisions to improving diagnostics and drug development and more.
The first two health systems to join this consortium are Sharp HealthCare, based in San Diego (“Sharp”), and Sanford Health based in Sioux Falls, South Dakota (“Sanford”). The consortium is in active discussions with additional health systems to ultimately reach a total of five large health system partners, representing rural and urban populations from different regions across the country.
AI holds much promise to improve healthcare delivery and outcomes; however, many AI products are built on narrow datasets that do not represent the diversity of the U.S. population and its care practices.
The emergence of the Dandelion Platform is meaningful because it captures a broad cross-section of U.S. healthcare. The underlying clinical data provides a diverse foundation for the Dandelion Platform, combining data from populations in large metropolitan areas and smaller communities nationwide as well as myriad care practices and a variety of diagnostics and imaging.
It is also enabling healthcare systems to be more involved in the development of AI products. “Sanford Health serves a diverse population across our 250,000 square-mile footprint, with two-thirds of our patients living in rural areas. It is vital that all patients, regardless of where they live, are included in the data as well as have access to modern healthcare,” said Kent Lehr, Sanford Health Chief Business Development Officer. “We believe this collaboration with Dandelion and Sharp will strengthen the ways we are able to deliver care and improve lives.”